Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P₁ lactam moieties as L-glutamine replacementsDRAGOVICH, P. S; PRINS, T. J; BURKE, B. J et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 7, pp 1213-1224, issn 0022-2623Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesDRAGOVICH, P. S; WEBBER, S. E; LITTLEFIELD, E. S et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 15, pp 2806-2818, issn 0022-2623Article